25 May 2013
Keywords: cell, thera, licenses, 65m, stock, investor, usa-based
Article | 05 May 2008
USA-based firm Cell Therapeutics has entered into an agreement to sell shares and securities worth approximately $64.5 million, or $0.79 per
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
5 May 2008
24 May 2013
© 2013 thepharmaletter.com